Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020
Laura J. Cremer, Amy Board, Gery P. Guy, Lyna Z. Schieber, Alice Asher, Erin Parker
Topics & Concepts
BuprenorphinePandemic(+)-NaloxoneNaltrexoneCoronavirus disease 2019 (COVID-19)PharmacyMedicine2019-20 coronavirus outbreakOpioid epidemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OpioidFamily medicineVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakReceptorOpioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskGun Ownership and Violence Research